Shikonin Inhibits Der p 2-Induced Cytokine and Chemokine Expression in Dendritic Cells in Patients with Atopic Dermatitis

Table 1

Demographic and clinical characteristics.

	Healthy subject (n = 7)	AD patients (n = 10)
Sex
Male	5 (71.4)	6 (60%)
Female	2 (28.6)	4 (40%)
Age (yrs)	41.1 ± 17.5	29.8 ± 11.1
EASI score	N. A	15.3 ± 11.7
IgE (IU/mL)	N. A	3335.2 ± 1779.2
Mite-specific IgE	N. A	10 (100%)
Topical steroid treatment	0 (0%)	10 (100%)
Systemic steroid treatment	0 (0%)	6 (60%)
Asthma	0 (0%)	5 (50%)
Rhinitis	2 (28.6)	6 (60%)
HBsAg	0 (0%)	0 (0%)
Anti-HCV	0 (0%)	1 (10%)
Autoimmune disease	0 (0%)	0 (0%)
Diabetes mellitus	1 (14.2%)	0 (0%)
Hypertension	1 (14.2%)	0 (0%)

Values are expressed as the number (percentage) or mean ± standard deviation.